Home » GlaxoSmithKline, Harvard Agree to $25 Million Deal
GlaxoSmithKline, Harvard Agree to $25 Million Deal
GlaxoSmithKline has entered into a 5-year, $25 million drug-development deal with Harvard University, the pharmaceutical giant said.
Triangle Business Journal
Triangle Business Journal
Upcoming Events
-
07May
-
14May
-
30May